Darunavir Sandoz 300 mg film-coat. tabl.

Nazione: Belgio

Lingua: inglese

Fonte: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Principio attivo:

Darunavir 300 mg

Commercializzato da:

Sandoz SA-NV

Codice ATC:

J05AE10

INN (Nome Internazionale):

Darunavir

Dosaggio:

300 mg

Forma farmaceutica:

Film-coated tablet

Composizione:

Darunavir 300 mg

Via di somministrazione:

Oral use

Area terapeutica:

Darunavir

Dettagli prodotto:

CTI code: 509022-06 - Pack size: 120 (120 x 1) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 509022-05 - Pack size: 120 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 509022-04 - Pack size: 90 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 509022-03 - Pack size: 60 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 509031-01 - Pack size: 120 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 509022-02 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 509022-01 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription

Stato dell'autorizzazione:

Commercialised: No

Data dell'autorizzazione:

2017-05-04